Results 41 to 50 of about 2,453,246 (260)

A brief overview of current drug repurposing approaches for COVID-19 management [PDF]

, 2020
This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares, Thomaz, Douglas Vieira   +1 more
core   +2 more sources

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 1)

Zdorovʹe Rebenka, 2018
The review of the literature presents the classification of antioxidant drugs. Modern data are presented on the inhibitors of NOX activity such as natural, synthetic (non-selective and selective), renin-angiotensin-aldosterone system blo­cking drugs and ...
A.E. Abaturov, A.P. Volosovets, T.P. Borysova   +2 more
doaj   +1 more source

2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs [PDF]

, 2016
This report represents a scientific and working clinical consensus statement on seizure management in dogs based on current literature and clinical expertise.
Bunch SE, Bunch SE, Cheuk DK, Cunningham JG, Dayrell‐Hart B, Durkes TE, Dyer KR, E.E. Patterson, Farnbach GC, Farnbach GC, Forrester SD, Frey HH, Gaskill CL, Gaskill CL, H.A. Volk, Jacobs G, Jennings PB, K. Muñana, Kantrowitz LB, M. Berendt, M. Podell, March PA, Masuda Y, Nichols ES, Patterson E, Pearce L, Pedersoli WM, Perrucca E, Poffenbarger EM, Ravis WR, S.R. Platt, Schwartz‐Porsche D, Schwartz‐Porsche D, Steinberg M, Thurman GD, Trepanier LA, Trepanier LA, W. Löscher   +37 more
core   +2 more sources

Contextualized Drug–Drug Interaction Management Improves Clinical Utility Compared With Basic Drug–Drug Interaction Management in Hospitalized Patients

Clinical Pharmacology & Therapeutics, 2022
Drug–drug interactions (DDIs) frequently trigger adverse drug events or reduced efficacy. Most DDI alerts, however, are overridden because of irrelevance for the specific patient. Basic DDI clinical decision support (CDS) systems offer limited possibilities for decreasing the number of irrelevant DDI alerts without missing relevant ones.
Arthur T.M. Wasylewicz, Britt W.M. van de Burgt, Thomas Manten, Marieke Kerskes, Wilma N. Compagner, Erik H.M. Korsten, Toine C.G. Egberts, Rene J.E. Grouls   +7 more
openaire   +5 more sources

Drug Management Reviews in District Drug Management Unit and General Hospital [PDF]

, 2009
Drug is one of the essential elements in healthcare that should be effectively and efficiently managed. Following the decentralization in 2001 in Indonesia, drug management has changed in district drug management units and also in District General ...
Handayani, R. S. (Rini), Herman, M. J. (Max), Yuniar, Y. (Yuyun)   +2 more
core  

The Diagnostic and Management of Drug Induced Esophagitis [PDF]

, 2002
There are several factors that involve in drug induced esophagitis such as: drugs, esophagus, patients. The drug can cause direct effect to the esophageal mucosa. The drugs that often cause esphagitis: alendronate, tetracycline and its derivates and anti
Bahar, A. (Alkindi), Manan, C. (Chudahman), Syam, A. F. (Ari)   +2 more
core   +1 more source

An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans [PDF]

, 2006
Provides a detailed assessment of the formularies, drug costs, and utilization management tools offered by the fourteen nationwide organizations that account for most of the stand-alone prescription drug ...
Elizabeth Hargrave, Jack Hoadley, Juliette Cubanski, Tricia Neuman   +3 more
core  

Development and Evaluation of Drug Management Information System in Mijen Community Health Center Demak

Jurnal Manajemen dan Pelayanan Farmasi
Background: Drug management information systems can serve as tools for decision-making. The effectiveness of such a system can be assessed through evaluation. One of the evaluation methods used is the PIECES method.
Faza Putri Farihatus Sholehah, Iswandi Iswandi, Jason Merari Peranginangin   +2 more
doaj   +1 more source

Deprescribing: Fashion Accessory or Fig Leaf?

Pharmacy, 2019
Deprescribing is the general practice fashion accessory that no prescriber can be seen without. However, it is in danger of becoming a “fig leaf” substitute for the entire medication review suite.
Arnold G. Zermansky
doaj   +1 more source

Pharmaceutical Exports of Iran in OIC Region and Entering International Markets

Journal of Pharmacoeconomics and Pharmaceutical Management, 2023
There are various pharmaceutical companies in Iran with high potential. Due to the lack of business with international markets for exports, Iranian pharmaceutical products are mostly traded in domestic markets. Despite numerous studies on pharmaceutical
Setareh Akhtarshenas, Hoda Yasini, Hossein Rastegar   +2 more
doaj   +1 more source